Safety of Combination TARE and SBRT in Hepatocellular Carcinoma: A Review of Literature & Single-Center Case Series

Hepatocellular carcinoma (HCC) is the most common primary liver cancer. At the time of diagnosis, many HCC patients are not candidates for surgical resection and are considered for other locoregional therapies, including transarterial radioembolization (TARE) and stereotactic body radiation therapy...

詳細記述

書誌詳細

出版年:	Current Oncology
主要な著者:	Bahareh Gholami, Ali Afrasiabi, Andrew M. Moon, Ted K. Yanagihara, Hui Wang, Sandra Gad, Alex Villalobos, David M. Mauro, Hyeon Yu, Johannes L. du Pisanie, Nima Kokabi
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-08-01
主題:	hepatocellular carcinoma transarterial radioembolization stereotactic body radiation therapy
オンライン･アクセス:	https://www.mdpi.com/1718-7729/32/9/487